Clovis Oncology, Inc. CLVSQ

Market cap
$14.2M
P/E
0.0×
Growth Flags show if company had growth for consecutive years

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Cash and Short Term Investments
266.18 563.73 520.15 296.66 240.23 143.43
Receivables
0.12 6.18 12.89 20.56 26.51 26.87
Inventory
— 27.51 27.07 26.52 30.71 13.69
Other current assets
6.68 27.96 8.61 18.85 9.13 11.71
Total current assets
279.41 626.94 572.30 366.47 310.83 198.09
Property, Plant, Equpment (Net)
4.44 4.01 26.52 15.29 12.09 6.55
Goodwill and Intangible Assets (Total)
78.24 84.78 115.00 125.99 128.82 123.45
Long-term assets (Other)
2.47 19.51 149.73 133.71 123.39 125.64
Total non-current assets
85.15 108.29 291.26 303.14 294.73 274.75
Total Assets
364.56 735.23 863.56 669.60 605.55 472.83
Accounts Payable
10.91 15.15 28.52 32.24 26.69 27.31
Accrued Expenses
35.20 18.47 29.68 53.21 43.50 35.12
Current Part of Debt
— 22.02 1.03 5.41 64.20 11.91
Other current liabilities
54.69 22.02 95.35 91.94 87.80 8.50
Total current liabilities
65.60 81.52 125.75 133.08 184.93 125.21
Long Term Debt (Total)
281.13 282.41 575.47 679.74 545.76 606.73
Non-current Revenue (Deferred)
1.41 3.67 15.87 — — —
Long Term Tax Liability (Deferred)
(31.77) (3.22) — — — —
Non-current Liabilities (Other)
20.06 0.00 15.87 1.56 1.97 —
Total non-current liabilities
302.59 286.08 591.34 710.78 579.37 626.46
Total liabilities
368.19 367.59 717.09 843.86 764.30 751.67
Additional Paid In Capital
1,174.95 1,887.20 2,034.14 2,114.07 2,498.18 2,641.71
Common Stock (Net)
0.04 0.05 0.05 0.06 0.10 0.13
Retained Earnings
(1,131.04) (1,477.44) (1,843.09) (2,243.51) (2,612.73) (2,877.25)
Common Equity (Total)
(3.63) 367.64 146.47 (174.26) (158.75) (278.84)
Shareholders Equity (Total)
(3.63) 367.64 146.47 (174.26) (158.75) (278.84)
Shareholders Equity and Liabilities (Total)
364.56 735.23 863.56 669.60 605.55 472.83
Shares (Common)
38.72 50.57 52.80 54.96 103.70 129.11
Shareholders Equity (Tangible)
(81.87) 282.86 31.47 (300.25) (287.56) (402.28)
Net Debt
14.94 (259.30) 56.36 388.49 369.73 475.21
Total Debt
281.13 304.43 576.50 685.15 609.96 618.64

Fold the line items

In millions of $ except per-share values · columns are period end dates